Sonocine, Inc. develops advanced medical systems for breast cancer screening and diagnostic imaging. Their flagship product, SonoCiné AWBUS (Automated Whole Breast Ultrasound), is designed to complement mammography, particularly for women with dense breast tissue. The company focuses on improving early detection rates and providing more comprehensive breast imaging solutions for healthcare providers in the United States.
The SonoCiné technology has demonstrated success in detecting cancers missed by traditional mammography, as evidenced by testimonials from medical professionals like Dr. Daniel Herron. By offering an additional screening option, Sonocine aims to enhance breast cancer detection rates and potentially save lives through earlier diagnosis. The company provides resources for patients and doctors to learn about their technology and locate SonoCiné providers.
